Alpha lipoic acid in burning mouth syndrome--a randomized double-blind placebo-controlled trial.

@article{Cavalcanti2009AlphaLA,
  title={Alpha lipoic acid in burning mouth syndrome--a randomized double-blind placebo-controlled trial.},
  author={Desir{\'e}e Rosa Cavalcanti and Fernando Ricardo Xavier da Silveira},
  journal={Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology},
  year={2009},
  volume={38 3},
  pages={254-61}
}
UNLABELLED The burning mouth syndrome (BMS) is a chronic condition characterized by oral burning pain in the absence of clinical abnormalities and without established therapy. OBJECTIVES The purpose of this study was to evaluate the effectiveness of alpha lipoic acid (ALA) in the management of BMS symptoms through a randomized double-blind placebo-controlled trial. METHODS Thirty-eight patients (34 women and four men, median age 62.9 years, range 36-78) were included and 31 completed the… CONTINUE READING